» Articles » PMID: 35916975

A Review of Molecular Interplay Between Neurotrophins and MiRNAs in Neuropsychological Disorders

Overview
Journal Mol Neurobiol
Date 2022 Aug 2
PMID 35916975
Authors
Affiliations
Soon will be listed here.
Abstract

Various neurotrophins (NTs), including nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, promote cellular differentiation, survival, and maintenance, as well as synaptic plasticity, in the peripheral and central nervous system. The function of microRNAs (miRNAs) and other small non-coding RNAs, as regulators of gene expression, is pivotal for the appropriate control of cell growth and differentiation. There are positive and negative loops between NTs and miRNAs, which exert modulatory effects on different signaling pathways. The interplay between NTs and miRNAs plays a crucial role in the regulation of several physiological and pathological brain procedures. Emerging evidence suggests the diagnostic and therapeutic roles of the interactions between NTs and miRNAs in several neuropsychological disorders, including epilepsy, multiple sclerosis, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, schizophrenia, anxiety disorders, depression, post-traumatic stress disorder, bipolar disorder, and drug abuse. Here, we review current data regarding the regulatory interactions between NTs and miRNAs in neuropsychological disorders, for which novel diagnostic and/or therapeutic strategies are emerging. Targeting NTs-miRNAs interactions for diagnostic or therapeutic approaches needs to be validated by future clinical studies.

Citing Articles

Peripheral Brain-Derived Neurotrophic Factor (BDNF) and Its Regulatory miRNAs as Biological Correlates of Impulsivity in Young Adults.

Zakowicz P, Narozna B, Kozlowski T, Bargiel W, Grabarczyk M, Terczynska M Metabolites. 2024; 14(10).

PMID: 39452910 PMC: 11509573. DOI: 10.3390/metabo14100529.


Boltzmann's Theorem Revisited: Inaccurate Time-to-Action Clocks in Affective Disorders.

Ferber S, Weller A, Soreq H Curr Neuropharmacol. 2024; 22(11):1762-1777.

PMID: 38500272 PMC: 11284727. DOI: 10.2174/1570159X22666240315100326.


Unraveling the Role of miR-200b-3p in Attention-Deficit/Hyperactivity Disorder (ADHD) and Its Therapeutic Potential in Spontaneously Hypertensive Rats (SHR).

Chang T, Lin H, Tzang C, Liang J, Hsu T, Tzang B Biomedicines. 2024; 12(1).

PMID: 38255250 PMC: 10813109. DOI: 10.3390/biomedicines12010144.


Detection of APP gene recombinant in human blood plasma.

Mitsunaga S, Fujito N, Nakaoka H, Imazeki R, Nagata E, Inoue I Sci Rep. 2023; 13(1):21703.

PMID: 38066066 PMC: 10709617. DOI: 10.1038/s41598-023-48993-7.


SIRT1, a target of miR-708-3p, alleviates fluoride-induced neuronal damage via remodeling mitochondrial network dynamics.

Zhao Q, Zhou G, Niu Q, Chen J, Li P, Tian Z J Adv Res. 2023; 65:197-210.

PMID: 38036217 PMC: 11519017. DOI: 10.1016/j.jare.2023.11.032.


References
1.
Wong J . Regulation of a TrkB Alternative Transcript by microRNAs. Dement Geriatr Cogn Dis Extra. 2014; 4(3):364-74. PMC: 4202609. DOI: 10.1159/000365917. View

2.
Yang S, Tang W, He Y, Wen L, Sun B, Li S . Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor. Cell Death Dis. 2018; 9(2):99. PMC: 5833397. DOI: 10.1038/s41419-017-0155-8. View

3.
Piotrzkowska D, Miller E, Kucharska E, Niwald M, Majsterek I . Association of miRNA and mRNA Levels of the Clinical Onset of Multiple Sclerosis Patients. Biology (Basel). 2021; 10(6). PMC: 8234685. DOI: 10.3390/biology10060554. View

4.
Piao J, Wu W, Yang Z, Li Y, Luo Q, Yu J . MicroRNA-381 Favors Repair of Nerve Injury Through Regulation of the SDF-1/CXCR4 Signaling Pathway via LRRC4 in Acute Cerebral Ischemia after Cerebral Lymphatic Blockage. Cell Physiol Biochem. 2018; 46(3):890-906. DOI: 10.1159/000488821. View

5.
Colucci-DAmato L, Speranza L, Volpicelli F . Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci. 2020; 21(20). PMC: 7589016. DOI: 10.3390/ijms21207777. View